 | • レポートコード：MRC2203A742 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料では、世界の吻合用デバイス市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、有用性別（使い捨て、再利用可能）分析、種類別（手術用ステープラー、手術用縫合糸、手術用シーラント・接着剤、その他）分析、用途別（心臓血管手術、消化器手術、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の吻合用デバイス市場規模：有用性別（使い捨て、再利用可能） ・世界の吻合用デバイス市場規模：種類別（手術用ステープラー、手術用縫合糸、手術用シーラント・接着剤、その他） ・世界の吻合用デバイス市場規模：用途別（心臓血管手術、消化器手術、その他） ・世界の吻合用デバイス市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Baxter International Inc. (Synovis Micro Companies Alliance)、Medtronic PLC、LivaNova PLC、...） ・市場機会・将来の傾向 |
The anastomosis devices market was anticipated to register a CAGR of 7.0% during the forecast period. The major factors driving the growth of the market are the increase in the number of cardiac and gastrointestinal surgeries globally. This resulted in increased use during the procedures. Higher demand for surgeries, like CABG (Coronary Artery Bypass Grafting), Partial colectomy, and other thoracic surgeries, due to the global prevalence of various coronary heart diseases and the rise in the geriatric population. For instance, according to WHO, 17.9 million of the population die every year. Additionally, cardiac diseases, like coronary heart disease, hypertension, and stroke, were ranked as the prominent causes of deaths worldwide. Furthermore, the increased adoption of endoscopic surgeries, favorable reimbursement policies, and technological advancements are expected to fuel the growth of the market.
Key Market Trends
The Cardiovascular Surgery Segment is Expected to Hold the Largest Market Share in the Anastomosis Devices Market
Cardiovascular surgeries, by application, are expected to witness the largest market share in the anastomosis devices market during the forecast period. This dominance is due to the increased use of various devices, such as the surgical staplers, and surgical sealants and adhesives in various cardiac surgeries. The increased demand for these devices in aortic surgery, arrhythmia surgery, myectomy, and CABG procedures can be attributed to their ability to minimize the risk of complications and reduce anastomotic leaks. Furthermore, the increasing number of cardiac diseases demands technologically advanced products, propelling the growth of the segment. On the other hand, the gastrointestinal surgeries segment is anticipated to witness the highest CAGR over the course of the forecast period. The lucrative growth of the segment can be due to the rising number of gastrointestinal cancers across the world. As per the American Cancer Society’s estimates for the year 2020, stomach cancer affects about 27,600 and causing 11,010 deaths in the United States. Also, the report states that surgery like endoscopic resection, partial gastrectomy, etc., can only offer a realistic chance for cure of this type of cancer. Thus, the adoption of surgery as an essential part of the treatment for many different stages of stomach cancer is expected to boost the growth of the segment.
North America Dominates the Market and Expected to do Same in the Forecast Period.
North America is expected to dominate the overall anastomosis devices market throughout the forecast period. The major factors attributing to the growth are the increase in the global prevalence of multiple cardiovascular indications, like CAD, strokes, and gastric cancers, like adenocarcinoma, lymphoma, etc., Thus, a rise in surgical procedures increased the demand for these surgical devices. As per the American Heart Association, in 2018, nearly 92.1 million individuals in the US suffered from cardiovascular diseases leading to 3244 heart transplantations. Thus, the higher demand for these devices during surgical procedures drives the market in the region. Deskbound lifestyle, increasing geriatric population with chronic diseases in the region contribute to its outstanding share of revenue propelling the global anastomosis devices market.
Competitive Landscape
The anastomosis market is moderately competitive and consists of several major players. Few of the key players are developing novel products and technologies to compete with the products trending in the market. For instance, in September 2019, Ethicon launched its ECHELON CIRCULAR Powered Circular Stapler which utilizes an innovative Gripping Surface and 3D Stapling Technologies. The stapler is designed to reduce leaks without compromising perfusion. Such innovative launches are expected to impel the global anastomosis market growth throughout the forecast period. Some of the companies which are currently dominating the market are Medtronic PLC, LivaNova PLC, Getinge AB, Johnson & Johnson (Ethicon US, LLC), and Baxter International Inc. (Synovis Micro Companies Alliance Inc.)
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Number of Surgical Procedures like Colectomy, CABG and Others
4.2.2 Availability of Technologically Advanced Products and Reimbursement Policies
4.3 Market Restraints
4.3.1 Adoption of Minimally Invasive Procedures like Percutaneous Coronary Interventions
4.3.2 Highly Expensive Treatments and Lack of Advanced Healthcare Infrastructure
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Usage
5.1.1 Disposable
5.1.2 Reusable
5.2 By Type
5.2.1 Surgical Staplers
5.2.2 Surgical Sutures
5.2.3 Surgical Sealants and Adhesives
5.2.4 Other Types
5.3 By Application
5.3.1 Cardiovascular Surgery
5.3.2 Gastrointestinal Surgery
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United states
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Baxter International Inc. (Synovis Micro Companies Alliance)
6.1.2 Medtronic PLC
6.1.3 LivaNova PLC
6.1.4 Getinge AB
6.1.5 Johnson & Johnson (Ethicon US LLC.)
6.1.6 Meril Life Sciences Pvt. Ltd
6.1.7 Becton, Dickinson and Company
6.1.8 Intuitive Surgical Inc.
6.1.9 Boston Scientific Corporation
6.1.10 B. Braun Melsungen AG
7 MARKET OPPORTUNITIES AND FUTURE TRENDS